LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

Search

Quest Diagnostics Inc

Cerrado

SectorSanidad

174.49 -0.73

Resumen

Variación precio

24h

Actual

Mínimo

173.89

Máximo

176.67

Métricas clave

By Trading Economics

Ingresos

13M

235M

Ventas

31M

2.7B

P/B

Media del Sector

22.238

54.379

BPA

2.21

Rentabilidad por dividendo

1.81

Margen de beneficios

8.861

Empleados

55,000

EBITDA

-19M

488M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+7.35% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.81%

2.55%

Próximas Ganancias

22 jul 2025

Fecha Próximo Dividendo

21 jul 2025

Próxima Fecha de Ex Dividendo

4 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

745M

20B

Apertura anterior

175.22

Cierre anterior

174.49

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

123 / 382 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Quest Diagnostics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 may 2025, 23:20 UTC

Ganancias

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 may 2025, 23:48 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 may 2025, 23:43 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 may 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 may 2025, 23:24 UTC

Charlas de Mercado
Ganancias

Global Equities Roundup: Market Talk

13 may 2025, 23:24 UTC

Charlas de Mercado
Ganancias

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 may 2025, 22:58 UTC

Ganancias

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 may 2025, 22:58 UTC

Ganancias

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 may 2025, 22:58 UTC

Ganancias

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 may 2025, 22:58 UTC

Ganancias

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 may 2025, 22:38 UTC

Ganancias

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 may 2025, 22:38 UTC

Ganancias

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 may 2025, 22:37 UTC

Ganancias

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 may 2025, 22:36 UTC

Ganancias

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 may 2025, 22:35 UTC

Ganancias

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 may 2025, 22:34 UTC

Ganancias

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 may 2025, 22:33 UTC

Ganancias

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 may 2025, 22:33 UTC

Ganancias

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 may 2025, 22:33 UTC

Ganancias

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 may 2025, 22:30 UTC

Ganancias

Aristocrat Interim Dividend 44 Australian Cents/Share

13 may 2025, 22:30 UTC

Ganancias

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 may 2025, 22:29 UTC

Ganancias

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 may 2025, 22:28 UTC

Ganancias

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 may 2025, 21:15 UTC

Ganancias

Nu Holdings 1Q Rev $3.2B >NU

13 may 2025, 21:03 UTC

Principales Noticias

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 may 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

13 may 2025, 20:32 UTC

Ganancias

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 may 2025, 20:31 UTC

Ganancias

Alcon 1Q Sales $2.45B >ALC.EB

13 may 2025, 20:30 UTC

Ganancias

Alcon 1Q Rev $2.47B >ALC.EB

13 may 2025, 20:30 UTC

Ganancias

Alcon 1Q EPS 70c >ALC.EB

Comparación entre iguales

Cambio de precio

Quest Diagnostics Inc previsión

Precio Objetivo

By TipRanks

7.35% repunte

Estimación a 12 Meses

Media 188.83 USD  7.35%

Máximo 200 USD

Mínimo 175 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Quest Diagnostics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

7

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

175.87 / 176.5Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

123 / 382 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.